Pregabalin NDC 65862-758

Product information

Brand name (proprietary)

Pregabalin

Generic name (nonproprietary)

pregabalin

Active ingredients

Pregabalin — 25 mg/1

Dosage form

Capsule

Route

Oral

Labeler

Aurobindo Pharma Limited

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 205321

Marketing start

Mar 29, 2023

Listing expires

Dec 31, 2027

DEA schedule

CV

Identifiers

Product ID 65862-758_03c24a38-f80a-4acb-ab38-c747c13125d4SPL ID 03c24a38-f80a-4acb-ab38-c747c13125d4SPL set ID 11034861-eef2-4996-8082-afc3c1769171RxCUI 483438, 483440, 483442, 483444, 483446, 483448, 483450, 577127UNII 55JG375S6MUPC 0365862758903

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N465862075805 followed by a unit qualifier and the quantity Copy

Package 65862-0758-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Label details couldn’t be retrieved right now. Open the label on DailyMed.

Other NDCs under ANDA 205321

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.